Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Background: Carbapenems (ertapenem, imipenem, meropenem) are used to treat multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB), even if the published evidence is limited, particularly when it is otherwise difficult to identify the recommended four active drugs to be inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotgiu, Giovanni, D’Ambrosio, Lia, Centis, Rosella, Tiberi, Simon, Esposito, Susanna, Dore, Simone, Spanevello, Antonio, Migliori, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813232/
https://www.ncbi.nlm.nih.gov/pubmed/26985890
http://dx.doi.org/10.3390/ijms17030373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813232/
https://www.ncbi.nlm.nih.gov/pubmed/26985890
http://dx.doi.org/10.3390/ijms17030373

Ejemplares similares